胃腸疾患治療薬の世界市場：市場規模・現状・将来予測 (2019～2025年)

当レポートでは、世界の胃腸疾患治療薬の市場について分析し、業界の基本構造や背景事情・最新情勢、全体的な市場規模の動向見通し、種類別・用途別および地域別の詳細動向、企業別の市場シェア構造、主要企業のプロファイル、今後の市場成長の可能性・方向性などを調査しております。

第1章 分析概要

• 分析範囲
• 主な市場区分
• 分析対象企業
• 市場分析：種類別
  • 市場規模・成長率：種類別 (通算12年間分)
  • 経口薬
  • 非経口薬
• 市場分析：用途別
  • 市場規模・成長率：用途別 (通算12年間分)
  • 炎症性腸疾患 (IBD)
  • 過敏性大腸症候 (IBS)
• 分析目的
• 分析対象期間

第2章 世界市場の成長動向

• 胃腸疾患治療薬の市場規模
• 胃腸疾患治療薬の市場成長率の動向：地域別
  • 地域別の市場規模 (通算12年間分)
  • 地域別の市場シェア (過去6年間分)
• 産業動向
  • 市場の主な動向
  • 市場促進要因
  • 市場機会

第3章 主要企業の市場シェア

• 胃腸疾患治療薬の市場規模：メーカー別
  • 市場規模：メーカー別
  • 市場シェア：メーカー別
  • 市場集中度 (上位5社分、HHI指数)
• 主要企業の本社所在地・活動地域
• 主要企業の製品／ソリューション／サービス
• 胃腸疾患治療薬市場への参入時期
• 企業合併・買収 (M&A)／事業拡張計画

第4章 市場データの内訳：種類別・用途別

• 種類別の市場規模 (過去6年間分)
• 用途別の市場規模 (過去6年間分)

第5章 米国市場

• 胃腸疾患治療薬の市場規模 (過去6年間分)
• 国内の主要企業
• 市場規模：種類別
• 市場規模：用途別

第6章 欧州市場

第7章 中国市場

第8章 日本市場

第9章 東南アジア市場

第10章 インド市場

第11章 中南米市場

第12章 主要企業のプロファイル

• AbbVie
  • 企業基本データ
  • 企業概略・事業概要
  • 胃腸疾患治療薬事業：概略
  • 胃腸疾患治療薬事業：市場収益額 (過去6年間分)
  • 近年の主な動向
• Allergan
• Johnson & Johnson
• 武田薬品工業
• Novartis
• Pfizer
• Merck
• F. Hoffmann-La Roche
• Eli Lilly
• AstraZeneca
• Procter & Gamble
• Tillotts Pharma
• Shire Pharmaceuticals
• GlaxoSmithKline
• Amgen

第13章 市場予測

• 市場規模の予測値：地域別 (今後7年間分)
• 米国市場の予測
• 欧州市場の予測
• 中国市場の予測
• 日本市場の予測
• 東南アジア市場の予測
• インド市場の予測
• 中南米市場の予測
• 市場規模の予測値：製品別 (今後7年間分)
• 市場規模の予測値：用途別 (今後7年間分)

第14章 アナリストの見解／結論

第15章 付録

List of Tables and Figures

• Table Gastrointestinal Therapeutics Key Market Segments
• Table Key Players Gastrointestinal Therapeutics Covered
• Table Global Gastrointestinal Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
• Figure Global Gastrointestinal Therapeutics Market Size Market Share by Type 2014-2025
• Figure Oral Figures
• Table Key Players of Oral
• Figure Parenteral Figures
• Table Key Players of Parenteral
• Table Global Gastrointestinal Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
• Figure IBD Case Studies
• Figure Irritable Bowel Syndrome (IBS) Case Studies
• Figure Gastrointestinal Therapeutics Report Years Considered
• Table Global Gastrointestinal Therapeutics Market Size 2014-2025 (Million US$)
• Figure Global Gastrointestinal Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
• Table Global Gastrointestinal Therapeutics Market Size by Regions 2014-2025 (Million US$)
• Table Global Gastrointestinal Therapeutics Market Size by Regions 2014-2019 (Million US$)
• Table Global Gastrointestinal Therapeutics Market Share by Regions 2014-2019
• Figure Global Gastrointestinal Therapeutics Market Share by Regions 2014-2019
• Figure Global Gastrointestinal Therapeutics Market Share by Regions 2019
• Table Market Top Trends
• Table Global Gastrointestinal Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
• Table Global Gastrointestinal Therapeutics Market Share by Manufacturers (2014-2019)
• Figure Global Gastrointestinal Therapeutics Market Share by Manufacturers in 2018
• Table Global Gastrointestinal Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table Key Players Head office and Area Served
• Table Key Players Gastrointestinal Therapeutics Product/Solution/Service
• Table Date of Enter into Gastrointestinal Therapeutics Market
• Table Mergers & Acquisitions, Expansion Plans
• Table Global Gastrointestinal Therapeutics Market Size by Type (2014-2019) (Million US$)
• Table Global Gastrointestinal Therapeutics Market Size Share by Type (2014-2019)
• Figure Global Gastrointestinal Therapeutics Market Size Market Share by Type (2014-2019)
• Table Global Gastrointestinal Therapeutics Market Size by Application (2014-2019) (Million US$)
• Table Global Gastrointestinal Therapeutics Market Size Share by Application (2014-2019)
• Figure Global Gastrointestinal Therapeutics Market Size Market Share by Application (2014-2019)
• Figure Global Gastrointestinal Therapeutics Revenue Market Share by Application in 2018
• Figure United States Gastrointestinal Therapeutics Market Size 2014-2019 (Million US$)
• Table United States Key Players Gastrointestinal Therapeutics Revenue (2018-2019) (Million US$)
• Table United States Key Players Gastrointestinal Therapeutics Market Share (2018-2019)
• Table United States Gastrointestinal Therapeutics Market Size by Type (2014-2019) (Million US$)
• Table United States Gastrointestinal Therapeutics Market Share by Type (2014-2019)
• Table United States Gastrointestinal Therapeutics Market Size by Application (2014-2019) (Million US$)
• Table United States Gastrointestinal Therapeutics Market Share by Application (2014-2019)
• Figure Europe Gastrointestinal Therapeutics Market Size 2014-2019 (Million US$)
• Table Europe Key Players Gastrointestinal Therapeutics Revenue (2018-2019) (Million US$)
• Table Europe Key Players Gastrointestinal Therapeutics Market Share (2018-2019)
• Table Europe Gastrointestinal Therapeutics Market Size by Type (2014-2019) (Million US$)
• Table Europe Gastrointestinal Therapeutics Market Share by Type (2014-2019)
• Table Europe Gastrointestinal Therapeutics Market Size by Application (2014-2019) (Million US$)
• Table Europe Gastrointestinal Therapeutics Market Share by Application (2014-2019)
• Figure China Gastrointestinal Therapeutics Market Size 2014-2019 (Million US$)
• Table China Key Players Gastrointestinal Therapeutics Revenue (2018-2019) (Million US$)
• Table China Key Players Gastrointestinal Therapeutics Market Share (2018-2019)
• Table China Gastrointestinal Therapeutics Market Size by Type (2014-20189) (Million US$)
• Table China Gastrointestinal Therapeutics Market Share by Type (2014-2019)
• Table China Gastrointestinal Therapeutics Market Size by Application (2014-2019) (Million US$)
• Table China Gastrointestinal Therapeutics Market Share by Application (2014-2019)
• Figure Japan Gastrointestinal Therapeutics Market Size 2014-2019 (Million US$)
• Table Japan Key Players Gastrointestinal Therapeutics Revenue (2018-2019) (Million US$)
• Table Japan Key Players Gastrointestinal Therapeutics Market Share (2018-2019)
• Table Japan Gastrointestinal Therapeutics Market Size by Type (2014-2019) (Million US$)
• Table Japan Gastrointestinal Therapeutics Market Share by Type (2014-2019)
• Table Japan Gastrointestinal Therapeutics Market Size by Application (2014-2019) (Million US$)
• Table Japan Gastrointestinal Therapeutics Market Share by Application (2014-2019)
• Figure Southeast Asia Gastrointestinal Therapeutics Market Size 2014-2019 (Million US$)
• Table Southeast Asia Key Players Gastrointestinal Therapeutics Revenue (2018-2019) (Million US$)
• Table Southeast Asia Key Players Gastrointestinal Therapeutics Market Share (2018-2019)
• Table Southeast Asia Gastrointestinal Therapeutics Market Size by Type (2014-2019) (Million US$)
• Table Southeast Asia Gastrointestinal Therapeutics Market Share by Type (2014-2019)
• Table Southeast Asia Gastrointestinal Therapeutics Market Size by Application (2014-2019) (Million US$)
• Table Southeast Asia Gastrointestinal Therapeutics Market Share by Application (2014-2019)
• Figure India Gastrointestinal Therapeutics Market Size 2014-2019 (Million US$)
• Table India Key Players Gastrointestinal Therapeutics Revenue (2018-2019) (Million US$)
• Table India Key Players Gastrointestinal Therapeutics Market Share (2018-2019)
• Table India Gastrointestinal Therapeutics Market Size by Type (2014-2019) (Million US$)
• Table India Gastrointestinal Therapeutics Market Share by Type (2014-2019)
• Table India Gastrointestinal Therapeutics Market Size by Application (2014-2019) (Million US$)
• Table India Gastrointestinal Therapeutics Market Share by Application (2014-2019)
• Figure Central & South America Gastrointestinal Therapeutics Market Size 2014-2019 (Million US$)
• Table Central & South America Key Players Gastrointestinal Therapeutics Revenue (2018-2019) (Million US$)
• Table Central & South America Key Players Gastrointestinal Therapeutics Market Share (2018-2019)
• Table Central & South America Gastrointestinal Therapeutics Market Size by Type (2014-2019) (Million US$)
• Table Central & South America Gastrointestinal Therapeutics Market Share by Type (2014-2019)
• Table Central & South America Gastrointestinal Therapeutics Market Size by Application (2014-2019) (Million US$)
• Table Central & South America Gastrointestinal Therapeutics Market Share by Application (2014-2019)
• Table AbbVie Company Details
• Table AbbVie Revenue in Gastrointestinal Therapeutics Business (2014-2019) (Million US$)
• Figure AbbVie Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019)
• Table AbbVie Recent Development
• Table Allergan Company Details
• Table Allergan Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$)
• Figure Allergan Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019)
• Table Allergan Recent Development
• Table Johnson & Johnson Company Details
• Table Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$)
• Figure Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019)
• Table Johnson & Johnson Recent Development
• Table Takeda Company Details
• Table Takeda Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$)
• Figure Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019)
• Table Takeda Recent Development
• Table Novartis Company Details
• Table Novartis Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$)
• Figure Novartis Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019)
• Table Novartis Recent Development
• Table Pfizer Company Details
• Table Pfizer Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$)
• Figure Pfizer Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019)
• Table Pfizer Recent Development
• Table Merck Company Details
• Table Merck Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$)
• Figure Merck Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019)
• Table Merck Recent Development
• Table F. Hoffmann-La Roche Company Details
• Table F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$)
• Figure F. Hoffmann-La Roche Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019)
• Table F. Hoffmann-La Roche Recent Development
• Table Eli Lilly Company Details
• Table Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$)
• Figure Eli Lilly Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019)
• Table Eli Lilly Recent Development
• Table AstraZeneca Company Details
• Table AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2014-2019)(Million US$)
• Figure AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics Business (2014-2019)
• Table AstraZeneca Recent Development
• Table Procter & Gamble Company Details
• Table Tillotts Pharma Company Details
• Table Shire Pharmaceuticals Company Details
• Table GlaxoSmithKline Company Details
• Table Amgen Company Details
• Table Global Gastrointestinal Therapeutics Market Size by Regions (Million US$) 2019-2025
• Figure Global Gastrointestinal Therapeutics Market Size Share by Regions (2019-2025)
• Figure Global Gastrointestinal Therapeutics Market Size Share by Regions in 2025
• Figure United States Gastrointestinal Therapeutics Market Size Forecast (2019-2025)(Million USD)
• Figure Europe Gastrointestinal Therapeutics Market Size Forecast (2019-2025)(Million USD)
• Figure China Gastrointestinal Therapeutics Market Size Forecast (2019-2025)(Million USD)
• Figure Japan Gastrointestinal Therapeutics Market Size Forecast (2019-2025)(Million USD)
• Figure Southeast Asia Gastrointestinal Therapeutics Market Size Forecast (2019-2025)(Million USD)
• Figure India Gastrointestinal Therapeutics Market Size Forecast (2019-2025)(Million USD)
• Figure Central & South America Gastrointestinal Therapeutics Market Size Forecast (2019-2025)(Million USD)
• Table Global Gastrointestinal Therapeutics Market Size by Product (2019-2025) (Million US$)
• Figure Global Gastrointestinal Therapeutics Market Size by Product (2019-2025)
• Figure Global Gastrointestinal Therapeutics Market Size by Product in 2025
• Table Global Gastrointestinal Therapeutics Market Size by Application (2019-2025) (Million US$)
• Figure Global Gastrointestinal Therapeutics Market Size by Application (2019-2025)
• Figure Global Gastrointestinal Therapeutics Market Size by Application in 2025
• Table Research Programs/Design for This Report
• Figure Bottom-up and Top-down Approaches for This Report
• Figure Data Triangulation
• Table Key Data Information from Secondary Sources
• Table Key Data Information from Primary Sources

Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.

Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn's disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.

In terms of geographical regions, the Americas will account for almost 50% of the total market shares and will also be the major revenue contributor to the gastrointestinal therapeutics market throughout the forecast period. The rising acceptance of biologics and the introduction of healthcare reforms by various countries in the region will augment the market's growth prospects in the next few years.

In 2018, the global Gastrointestinal Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gastrointestinal Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastrointestinal Therapeutics development in United States, Europe and China.

The key players covered in this study

• AbbVie
• Allergan
• Johnson & Johnson
• Takeda
• Novartis
• Pfizer
• Merck
• F. Hoffmann-La Roche
• Eli Lilly
• AstraZeneca
• Procter & Gamble
• Tillotts Pharma
• Shire Pharmaceuticals
• GlaxoSmithKline
• Amgen

Market segment by Type, the product can be split into

• Oral
• Parenteral

Market segment by Application, split into

• IBD
• Irritable Bowel Syndrome (IBS)

Market segment by Regions/Countries, this report covers

• United States
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Gastrointestinal Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Gastrointestinal Therapeutics development in United States, Europe and China.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gastrointestinal Therapeutics are as follows:

• History Year: 2014-2018
• Base Year: 2018
• Estimated Year: 2019
• Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Oral
  • 1.4.3 Parenteral
• 1.5 Market by Application
  • 1.5.1 Global Gastrointestinal Therapeutics Market Share by Application (2014-2025)
  • 1.5.2 IBD
  • 1.5.3 Irritable Bowel Syndrome (IBS)
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Gastrointestinal Therapeutics Market Size
• 2.2 Gastrointestinal Therapeutics Growth Trends by Regions
  • 2.2.1 Gastrointestinal Therapeutics Market Size by Regions (2014-2025)
  • 2.2.2 Gastrointestinal Therapeutics Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Gastrointestinal Therapeutics Market Size by Manufacturers
  • 3.1.1 Global Gastrointestinal Therapeutics Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI)
• 3.2 Gastrointestinal Therapeutics Key Players Head office and Area Served
• 3.3 Key Players Gastrointestinal Therapeutics Product/Solution/Service
• 3.4 Date of Enter into Gastrointestinal Therapeutics Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Gastrointestinal Therapeutics Market Size by Type (2014-2019)
• 4.2 Global Gastrointestinal Therapeutics Market Size by Application (2014-2019)

5 United States

• 5.1 United States Gastrointestinal Therapeutics Market Size (2014-2019)
• 5.2 Gastrointestinal Therapeutics Key Players in United States
• 5.3 United States Gastrointestinal Therapeutics Market Size by Type
• 5.4 United States Gastrointestinal Therapeutics Market Size by Application

6 Europe

• 6.1 Europe Gastrointestinal Therapeutics Market Size (2014-2019)
• 6.2 Gastrointestinal Therapeutics Key Players in Europe
• 6.3 Europe Gastrointestinal Therapeutics Market Size by Type
• 6.4 Europe Gastrointestinal Therapeutics Market Size by Application

7 China

• 7.1 China Gastrointestinal Therapeutics Market Size (2014-2019)
• 7.2 Gastrointestinal Therapeutics Key Players in China
• 7.3 China Gastrointestinal Therapeutics Market Size by Type
• 7.4 China Gastrointestinal Therapeutics Market Size by Application

8 Japan

• 8.1 Japan Gastrointestinal Therapeutics Market Size (2014-2019)
• 8.2 Gastrointestinal Therapeutics Key Players in Japan
• 8.3 Japan Gastrointestinal Therapeutics Market Size by Type
• 8.4 Japan Gastrointestinal Therapeutics Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Gastrointestinal Therapeutics Market Size (2014-2019)
• 9.2 Gastrointestinal Therapeutics Key Players in Southeast Asia
• 9.3 Southeast Asia Gastrointestinal Therapeutics Market Size by Type
• 9.4 Southeast Asia Gastrointestinal Therapeutics Market Size by Application

10 India

• 10.1 India Gastrointestinal Therapeutics Market Size (2014-2019)
• 10.2 Gastrointestinal Therapeutics Key Players in India
• 10.3 India Gastrointestinal Therapeutics Market Size by Type
• 10.4 India Gastrointestinal Therapeutics Market Size by Application

11 Central & South America

• 11.1 Central & South America Gastrointestinal Therapeutics Market Size (2014-2019)
• 11.2 Gastrointestinal Therapeutics Key Players in Central & South America
• 11.3 Central & South America Gastrointestinal Therapeutics Market Size by Type
• 11.4 Central & South America Gastrointestinal Therapeutics Market Size by Application

12 International Players Profiles

• 12.1 AbbVie
  • 12.1.1 AbbVie Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Gastrointestinal Therapeutics Introduction
  • 12.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2014-2019)
  • 12.1.5 AbbVie Recent Development
• 12.2 Allergan
  • 12.2.1 Allergan Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Gastrointestinal Therapeutics Introduction
  • 12.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2014-2019)
  • 12.2.5 Allergan Recent Development
• 12.3 Johnson & Johnson
  • 12.3.1 Johnson & Johnson Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Gastrointestinal Therapeutics Introduction
  • 12.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2014-2019)
  • 12.3.5 Johnson & Johnson Recent Development
• 12.4 Takeda
  • 12.4.1 Takeda Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Gastrointestinal Therapeutics Introduction
  • 12.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2014-2019)
  • 12.4.5 Takeda Recent Development
• 12.5 Novartis
  • 12.5.1 Novartis Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Gastrointestinal Therapeutics Introduction
  • 12.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2014-2019)
  • 12.5.5 Novartis Recent Development
• 12.6 Pfizer
  • 12.6.1 Pfizer Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Gastrointestinal Therapeutics Introduction
  • 12.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2014-2019)
  • 12.6.5 Pfizer Recent Development
• 12.7 Merck
  • 12.7.1 Merck Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Gastrointestinal Therapeutics Introduction
  • 12.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2014-2019)
  • 12.7.5 Merck Recent Development
• 12.8 F. Hoffmann-La Roche
  • 12.8.1 F. Hoffmann-La Roche Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Gastrointestinal Therapeutics Introduction
  • 12.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2014-2019)
  • 12.8.5 F. Hoffmann-La Roche Recent Development
• 12.9 Eli Lilly
  • 12.9.1 Eli Lilly Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Gastrointestinal Therapeutics Introduction
  • 12.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2014-2019)
  • 12.9.5 Eli Lilly Recent Development
• 12.10 AstraZeneca
  • 12.10.1 AstraZeneca Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Gastrointestinal Therapeutics Introduction
  • 12.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2014-2019)
  • 12.10.5 AstraZeneca Recent Development
• 12.11 Procter & Gamble
• 12.12 Tillotts Pharma
• 12.13 Shire Pharmaceuticals
• 12.14 GlaxoSmithKline
• 12.15 Amgen

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer
• 15.3 Author Details